Menu
Recruiting NCT07220343

Digital Phenotyping for Psychosocial Screening in Adolescents and Young Adults With Cancer

No phase Interventional Cancer Adolescents

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Device, Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App.
Who it may be relevant to
Registry conditions: Cancer, Adolescents. Basic parameters: 10 years — 25 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Using Digital Phenotyping to Optimize Psychosocial Risk Screening and Personalized Care: a Pilot Study in Adolescents and Young Adults With Cancer

Overview

The overall goal of the proposed study is to use digital phenotyping to identify and triage at-risk patients and accelerate access to critical mental health services.

Interventions

  • Device Device
    Participants will wear a wrist-based wearable device for 10 days to passively track physiological data (heart rate, steps, sleep, etc.).
  • Behavioral Ecological Momentary Assessment (EMA) via My Personal Health Dashboard (MyPHD) Smartphone App
    Participants will respond to ecological momentary assessments (EMA) via smartphone to actively report on sleep, mood, stress, and eating habits across a 10-day period.

Primary outcome measures

  • Change in Depressive Symptoms (Beck Depression Inventory - BDI) [Time frame: Baseline, Day 10, 2 months]
Secondary outcome measures (7)
  • Participant Retention Rate (MyPHD App and Wearable Device) [Time frame: Baseline to 2 months]
  • Adherence to EMA Prompts [Time frame: Baseline to 2 months]
  • Wearable Device Return and Use Rate [Time frame: Baseline to 2 months]
  • Change in Anxiety Symptoms (Beck Anxiety Inventory - BAI) [Time frame: Baseline, Day 10, 2 months]
  • Change in PTSD Symptoms (CROPS) [Time frame: Baseline]
  • Change in PTSD Symptoms (PCL-5) [Time frame: Baseline]
  • Change in Sleep Quality (Pittsburgh Sleep Quality Index - PSQI) [Time frame: Baseline, Day 10]

Eligibility criteria

Inclusion criteria

  • 10-25 years old
  • Recent cancer diagnosis (>2 and <18 months since diagnosis)
  • Willing to carry smartphone on their person for duration of study participation
  • Willing to wear smartwatch for duration of study participation

Exclusion criteria

  • Significant physical or mental disability that prevents completion of study activities
  • Lack of proficiency in English or Spanish

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Stanford University — Palo Alto

Identifiers

NCT: NCT07220343 · IRB-73748

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗